Opko Diagnostics, Llc

Opko Diagnostics, Llc company information, Employees & Contact Information

OPKO Diagnostics, LLC (formerly Claros Diagnostics) is part of OPKO Health, Inc. a publicly traded healthcare company involved in the discovery, development, and commercialization of pharmaceutical products, vaccines and diagnostic products. OPKO Diagnostics is creating innovative products to transition in-vitro medical diagnostic tests from the laboratory to the point-of-care, such as a physician's office, bedside, etc. Our technology platform provides anyone the ability to perform complex laboratory-quality assays in minutes with no training and at minimal cost.

Company Details

Employees
25
Address
4 Constitution Way, Suite F,united States
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Woburn, MA
Looking for a particular Opko Diagnostics, Llc employee's phone or email?

Opko Diagnostics, Llc Questions

News

OPKO Health to Report Third Quarter 2025 Financial Results on October 29 - GlobeNewswire

OPKO Health to Report Third Quarter 2025 Financial Results on October 29 GlobeNewswire

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results - OPKO Health, Inc.

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results OPKO Health, Inc.

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program - GlobeNewswire

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program GlobeNewswire

OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results - OPKO Health, Inc.

OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results OPKO Health, Inc.

BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business - OPKO Health, Inc.

BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business OPKO Health, Inc.

Leadership - OPKO Health, Inc.

Leadership OPKO Health, Inc.

OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland - OPKO Health, Inc.

OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland OPKO Health, Inc.

Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform - OPKO Health, Inc.

Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform OPKO Health, Inc.

BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball - OPKO Health, Inc.

BioReference Laboratories Expands Its Major League Sports Relationships with Addition of Major League Baseball OPKO Health, Inc.

OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services - OPKO Health, Inc.

OPKO Health’s GeneDx Enters into Agreement with Pediatrix Medical Group to Offer Neonatal Genomic Services OPKO Health, Inc.

OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada - OPKO Health, Inc.

OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada OPKO Health, Inc.

OPKO Health Licensee TESARO Announces FDA Approval of VARUBI - OPKO Health, Inc.

OPKO Health Licensee TESARO Announces FDA Approval of VARUBI OPKO Health, Inc.

OPKO Health Enters Companion Animal Health Market - OPKO Health, Inc.

OPKO Health Enters Companion Animal Health Market OPKO Health, Inc.

OPKO Completes Acquisition of Bio-Reference Laboratories - OPKO Health, Inc.

OPKO Completes Acquisition of Bio-Reference Laboratories OPKO Health, Inc.

Transition Therapeutics Shareholders Approve Acquisition by OPKO Health - OPKO Health, Inc.

Transition Therapeutics Shareholders Approve Acquisition by OPKO Health OPKO Health, Inc.

Terms of Use - OPKO Health, Inc.

Terms of Use OPKO Health, Inc.

OPKO Health Announces Move to NASDAQ Stock Market - OPKO Health, Inc.

OPKO Health Announces Move to NASDAQ Stock Market OPKO Health, Inc.

OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer - OPKO Health, Inc.

OPKO Health Receives FDA Approval for the Point-of-Care Sangia PSA Test with the Claros® 1 Analyzer OPKO Health, Inc.

OPKO Health Acquires EirGen Pharma - OPKO Health, Inc.

OPKO Health Acquires EirGen Pharma OPKO Health, Inc.

OPKO Health Announces New Listing on Tel Aviv Stock Exchange - OPKO Health, Inc.

OPKO Health Announces New Listing on Tel Aviv Stock Exchange OPKO Health, Inc.

OPKO Health Completes Acquisition of Transition Therapeutics - OPKO Health, Inc.

OPKO Health Completes Acquisition of Transition Therapeutics OPKO Health, Inc.

Vifor Fresenius Medical Care Renal Pharma and OPKO Health Enter into Agreement for OPKO’s RAYALDEE - OPKO Health, Inc.

Vifor Fresenius Medical Care Renal Pharma and OPKO Health Enter into Agreement for OPKO’s RAYALDEE OPKO Health, Inc.

OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis - OPKO Health, Inc.

OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis OPKO Health, Inc.

OPKO Health Appoints Pascal J. Goldschmidt to Board of Directors - OPKO Health, Inc.

OPKO Health Appoints Pascal J. Goldschmidt to Board of Directors OPKO Health, Inc.

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results - Yahoo Finance

OPKO Health Reports First Quarter 2025 Business Highlights and Financial Results Yahoo Finance

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results - Yahoo Finance

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results Yahoo Finance

OPKO Health Acquires Company Developing Novel Glaucoma Therapy - OPKO Health, Inc.

OPKO Health Acquires Company Developing Novel Glaucoma Therapy OPKO Health, Inc.

The Frost Group Invests $20 Million in OPKO Health - OPKO Health, Inc.

The Frost Group Invests $20 Million in OPKO Health OPKO Health, Inc.

OPKO Health Completes Acquisition of Ophthalmic Technologies, Inc. - OPKO Health, Inc.

OPKO Health Completes Acquisition of Ophthalmic Technologies, Inc. OPKO Health, Inc.

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck - Yahoo Finance

OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck Yahoo Finance

OPKO Health and Entera Bio Abstract for First-in-Class Dual - GlobeNewswire

OPKO Health and Entera Bio Abstract for First-in-Class Dual GlobeNewswire

OPKO Health’s ModeX Therapeutics Announces Formation of - GlobeNewswire

OPKO Health’s ModeX Therapeutics Announces Formation of GlobeNewswire

OPKO Health Q2 2025 Earnings Call: Financial Results and Business Update Coming July 31 - Stock Titan

OPKO Health Q2 2025 Earnings Call: Financial Results and Business Update Coming July 31 Stock Titan

OPKO Health Appoints Katherine Stueland as CEO of GeneDx - citybiz

OPKO Health Appoints Katherine Stueland as CEO of GeneDx citybiz

Top Opko Diagnostics, Llc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant